RespireRx Pharmaceuticals (RSPID) Stock Price, News & Analysis

Company Overview

RespireRx Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for neurological and respiratory disorders. Its research has centered on conditions involving impaired breathing and central nervous system dysfunction, including opioid-induced respiratory depression and sleep-related breathing disorders.

The company’s development programs have included ampakine compounds, such as CX1739, designed to enhance respiratory drive without directly stimulating opioid receptors. RespireRx has also investigated other central nervous system treatments, although the status and scope of its programs may change as development activities progress.

RespireRx was formerly known as Cortex Pharmaceuticals Inc. and adopted its current name to reflect its emphasis on respiratory therapeutics. The company is headquartered in the United States and has primarily operated as a development-stage pharmaceutical business. Publicly available information about its current leadership and commercial operations is limited.

Key Stats

• Today's Range: $0.0018 to $0.0018
• 50-Day Range: N/A
• 52-Week Range: $0.01 to $1.50
• Volume: 300 shs
• Average Volume: 928,930 shs
• Market Capitalization: $130.09 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:RSPID
• CIK: N/A
• Web: www.respirerx.com
• Phone: 201 444 4947
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 72,271,000
• Free Float: N/A
• Market Cap: $130.09 thousand
• Optionable: Not Optionable
• Beta: 0.15